The American Society of Transplantation Online Transplant Infectious Diseases Library
Full Library 1,504 resources
-
Invasive aspergillosis (IA) is a rare but fatal disease among liver transplant recipients (LiTRs). We performed a multi-center 1:2 case-control study comparing LiTRs diagnosed with proven/probable IA and controls with no invasive fungal infection. We included 62 IA cases and 124 matched controls. Disseminated infection occurred only in eight cases (13%). 12-week all-cause mortality of IA was 37%. In multivariate analyses, systemic antibiotics usage (adjusted odds ratio [aOR], 4.74; p=0.03)...
-
Abstract Background The implications of inherited chromosomally integrated human herpesvirus 6 (iciHHV-6) in solid organ transplantation remain uncertain. Although this trait has been linked to unfavorable clinical outcomes, an association between viral reactivation and complications has only been conclusively established in a few cases. Methods We used hybrid capture sequencing for in-depth...
-
Reactivation or primary infection with double-stranded DNA viruses is common in recipients of solid organ transplants (SOTs) and is associated with significant morbidity and mortality. Treatment with conventional antiviral medications is limited by toxicities, resistance, and a lack of effective options for adenovirus (ADV) and BK polyomavirus (BKPyV). Virus-specific T cells (VSTs) have been shown to be an effective treatment for infections with ADV, BKPyV, cytomegalovirus (CMV), and...
-
Mollicute infections, caused by Mycoplasma and Ureaplasma species, are serious complications after lung transplantation; however, understanding of the epidemiology and outcomes of these infections remains limited. We conducted a single-center retrospective study of 1156 consecutive lung transplants performed from 2010-2019. We used log-binomial regression to identify risk factors for infection and analyzed clinical management and outcomes. In total, 27 (2.3%) recipients developed mollicute...
-
Background: Norovirus (NoV) can cause chronic relapsing and remitting diarrhea in immunocompromised patients. Few multicenter studies have described the clinical course, outcomes, and complications of chronic NoV in transplant recipients.
-
Background. Co-infection of JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV) is uncommon in kidney transplant recipients, and the prognosis is unclear. This study aimed to investigate the effect of concurrent JCPyV-DNAemia on graft outcomes in BKPyV-infected kidney transplant recipients with polyomavirus-associated nephropathy (PyVAN). Methods. A total of 140 kidney transplant recipients with BKPyV replication and PyVAN,...
-
Mucormycosis is a rare and devastating angioinvasive infection that can be challenging to diagnose due to the low sensitivity of current noninvasive diagnostics and the lack of a “gold standard” reference test. We describe a retrospective case series of children with suspected mucormycosis where plasma microbial cell-free DNA testing was utilized in the diagnostic evaluation to illustrate the ways in which microbial cell-free DNA testing can noninvasively contribute to the evaluation and...
-
Background: The incidence of atypical pneumonia among immunocompromised patients is not well characterized. Establishing a diagnosis of atypical pneumonia is challenging as positive tests must be carefully interpreted. We aimed to assess the test positivity rate and incidence of atypical pneumonia in transplant recipients. Methods: A retrospective cohort study was conducted at the Yale New Haven Health System in Connecticut. Adults with solid organ transplant, hematopoietic stem cell...
-
Abstract We studied patients diagnosed with aspergillosis based on positive bronchoalveolar lavage (BAL) Aspergillus galactomannan (GM) who had follow-up BAL sampling within 180 days. GM trend and clinical outcome were concordant in only 60% (30/50). While useful for the initial diagnosis, BAL GM trending does not always correlate with treatment response.
-
Abstract Adverse outcomes of viral respiratory tract infections (RTIs) have been reported in recipients of allogeneic hematopoietic cell transplantation. Using a laboratory-developed multiparameter polymerase chain reaction in a consecutive series of 242 patients, we found the highest incidence of viral RTI in the preengraftment phase. The occurrence of multiple episodes of viral RTI or viral pneumonia was significantly associated with a higher hazard of nonrelapse mortality in...
-
Abstract Background Reducing the burden of multidrug-resistant organism (MDRO) colonization and infection among renal transplant recipients (RTRs) may improve patient outcomes. We aimed to assess whether the detection of an MDRO or a comparable antibiotic-susceptible organism (CSO) during the early post-transplant (EPT) period was associated with graft loss and mortality among RTRs. Methods ...
-
Abstract Streptococcus mitis commonly causes bloodstream infections (BSIs) in neutropenic patients but infrequently results in infective endocarditis (IE) in this population. Among 210 patients with neutropenia and S. mitis BSI, 55% underwent cardiac imaging. None were diagnosed with S. mitis IE; 3 had recurrent S. mitis BSI within 12 weeks.
-
Abstract Combination antifungal therapy for invasive mucormycosis remains controversial and is inconsistently defined in prior studies. In a cohort of immunocompromised patients with invasive mucormycosis, we found no difference in 6-week mortality with upfront nor salvage combination therapy compared to monotherapy.
-
Histoplasmosis is an endemic and invasive mycosis caused by Histoplasma capsulatum. We conducted a retrospective study comparing non-HIV immunosuppressed patients with a historical cohort of HIV and histoplasmosis. We included 199 patients with proven or probable histoplasmosis, of which 25.1% were non-HIV. Diabetes mellitus, chronic kidney disease, hematologic neoplasms, rheumatologic diseases and transplants were more frequent among non-HIV patients (p<0.01). Death after diagnosis...
-
Febrile neutropenia (FN) is common among hematologic malignancy patients, including recipients of hematopoietic cell transplantation (HCT) and cellular therapies such as chimeric antigen receptor (CAR)-T-cell therapy. Prompt empiric antibiotic use has been the mainstay for decades but a “one-size-fits-all” approach is no longer broadly accepted, as treatment-related infectious risk are more understood. Growing antimicrobial resistance is an increasing clinical challenge. Evolving strategies...
Filter by our tag
GUIDELINES
- AASLD Guidelines (5)
- AST Guidelines 2019 (44)
- ASTCT Guidelines 2019-2023 (9)
- DGHO Guidelines (3)
- ECIL Guidelines (18)
- ESCMID Guidelines (25)
- IDSA Guidelines (51)
- ISHLT Guidelines (11)
- NIH Guidelines (1)
TEXTBOOKS
CORE CURRICULUM
- BASICS OF TRANSPLANT (35)
- ORGANISMS (44)
- SYNDROMES (12)
ORGANISMS
-
BACTERIA
(154)
- C. difficile (23)
- Legionella (1)
- MDR GNR (37)
- MRSA (7)
- Mycoplasma and Ureaplasma (11)
- Nocardia (10)
- Non-tuberculous Mycobacteria (27)
- Syphilis (6)
- Tuberculosis (32)
- VRE (8)
-
FUNGI
(220)
- Aspergillus (58)
- Candida (47)
- Cryptococcus (28)
- Endemic mycoses (41)
- Mucormycosis (32)
- Pneumocystis (40)
- Rarer Fungi (22)
-
PARASITES AND PROTOZOA
(42)
- Chagas (9)
- Protozoa (11)
- Strongyloides (14)
- Toxoplasmosis (12)
-
VIRUSES
(379)
- Adenovirus (17)
-
CMV
(116)
- Cell-Mediated Immunity Assays (11)
- Clinical (56)
- Cytotoxic T-Lymphocytes (1)
- Epidemiology and Risk Factors (15)
- Letermovir (23)
- Maribavir (13)
- Preemptive Therapy (6)
-
COVID-19
(47)
- Diagnosis (4)
- Fungal superinfection (2)
- GUIDELINES (10)
- Infection Prevention (4)
- Positive Donors (6)
- Positive Recipients (5)
- Treatments (18)
- Vaccination (9)
- Hepatitis A (2)
- Hepatitis B (25)
- Hepatitis C (31)
- Hepatitis D (4)
- Hepatitis E (5)
- HHV-6 (22)
- HHV-8 (4)
- HIV (31)
- HPV (5)
- HSV (4)
- Influenza (17)
- Mpox (6)
- Norovirus (8)
- Parvovirus B19 (3)
- Polyomaviruses (31)
- Respiratory Viruses (31)
- RSV (18)
- VZV (17)
- WNV (2)
DIAGNOSTICS
- Advanced Diagnostics (21)
- Fungal diagnostics (40)
- Nuclear Medicine (7)
- Parasites (3)
- Procalcitonin (1)
- Viral diagnostics (1)
DRUGS AND THERAPIES
- Antibiotics (12)
- Antifungals (67)
- Antivirals (10)
- Cytotoxic T-lymphocyte therapy (6)
- Fecal Microbiota Transplantation (12)
- Phage therapy (4)
- Stewardship (57)
PREVENTION
- Infection Control (8)
- Safe Living (21)
- Travel (10)
- Vaccination (33)
SYNDROMES AND CONDITIONS
- Cirrhotics (11)
- CNS (3)
- Cytopenias (2)
- Diarrhea (13)
- Endovascular infections (12)
- Pneumonia (9)
- Surgical Infections (8)
- UTI (30)
SOLID ORGANS AND MCSS
- Donor (42)
- Heart (15)
- Immunosuppression (14)
- Intestinal (2)
- Kidney (31)
- Liver (50)
- Lung (69)
- LVAD (30)
- Pancreas (5)
- PEDIATRIC (39)
- Recipient (5)
- Total Artificial Heart (1)
- Vascular Composite Allograft (2)
- Xenotransplantation (3)
HEME-ONC AND CELLULAR THERAPIES
- Biologics (44)
- BMT Basics (5)
- BMT Guidelines (14)
- BMT Noninfectious (12)
- BMT-specific ID (69)
- CAR-T (21)
- CAR-T Noninfectious (3)
- GVHD (4)
- Heme malignancies (3)
- Heme-onc prophylaxis (24)
- Neutropenia (42)
- PEDIATRIC (32)
- PTLD (25)
- TK inhibitors (10)
TRANSPLANT ID TRAINING
- AST (4)
- Career Development (1)
- Fungal (5)
- Training program (6)
PATIENT EDUCATION
- COVID-19 (13)
- Food (10)
- Hygiene (4)
- Mpox (5)
- Pets (4)
- Safer living (16)
- Selected Infections (10)
- TB (10)
- Travel (3)
- Water safety (5)
JOURNAL CLUB
- 2024 (2)